Viewing data from:

PYRAZINAMIDE

ANDA

PYRAZINAMIDE | A212541 | MACLEODS PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.45

per ea

Lowest NADAC/Unit

$1.45

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
33342044711PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17
33342044715PYRAZINAMIDE 500 MG TABLET	$1.45	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

DELMAR CHEMICALS INCPYRAZINAMIDE

DMF 153252001

CALYX CHEMICALS AND PHARMACEUTICALS LTDPYRAZINAMIDE USP

DMF 155532001

MACLEODS PHARMACEUTICALS LTDPYRAZINAMIDE

DMF 304482016

MATRIX PHARMACORP PRIVATE LTDPYRAZINAMIDE USP

DMF 342292019

BRACCO IND CHIMICA SPAInactivePYRAZINAMIDE

DMF 59091985

NORISTON LTDInactivePYRAZINAMIDE

DMF 86041990

SANOFI AVENTISInactivePYRAZINAMIDE

DMF 146231999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 27, 2020

No patent or exclusivity listings for this strength.